Marion David

Title: Marion David: Innovator in Cancer Research

Introduction

Marion David is a prominent inventor based in Marseilles, France. She has made significant contributions to the field of cancer research, holding a total of 5 patents. Her work focuses on innovative methods for targeting cancer cells and improving therapeutic delivery.

Latest Patents

One of her latest patents is titled "Transferrin receptor-binding molecules, conjugates thereof and their uses." This invention relates to Variable Domain of Camelid Heavy Chain-only (VHH) molecules that bind to the transferrin receptor (TfR). These molecules are designed to transport pharmaceutical or diagnostic agents into cells and organs, particularly in pathological conditions such as cancer. Another notable patent is "Compositions and methods for cancer imaging and radiotherapy." This invention involves a conjugated compound that includes a pharmaceutically acceptable marker and a peptide or pseudo-peptide capable of binding the Low-Density Lipoprotein Receptor (LDLR). It is intended for use in labeling, detecting, and treating cancerous cells through the administration of the conjugated compound.

Career Highlights

Throughout her career, Marion David has worked with esteemed organizations such as Vect-Horus and the Centre National de la Recherche Scientifique. Her research has significantly advanced the understanding and treatment of cancer, showcasing her dedication to improving patient outcomes.

Collaborations

Marion has collaborated with notable professionals in her field, including Michel Khrestchatisky and Yves Molino. These partnerships have further enriched her research and contributed to her innovative work.

Conclusion

Marion David's contributions to cancer research through her patents and collaborations highlight her role as a leading inventor in the field. Her innovative approaches continue to pave the way for advancements in cancer treatment and diagnostics.